Nektar Therapeutics In Focus: Stock Rises 10.77% - Tale Of The Tape

Nektar Therapeutics NKTR was a big mover last session, as the company saw its shares rise nearly 11% on the day. This jump can be attributable to solid volume too with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $10.95 to $12.54 in the past one-month time frame.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, Friday's price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Nektar Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Other attractive players in the healthcare industry include Illumina Inc. ILMN carrying a Zacks Rank #1 (Strong Buy) along with Ariad Pharmaceuticals Inc. ARIA and Aeolus Pharmaceuticals Inc. (AOLS) with a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
NEKTAR THERAP NKTR: Free Stock Analysis Report
 
ILLUMINA INC ILMN: Free Stock Analysis Report
 
AEOLUS PHARMACT (AOLS): Get Free Report
 
ARIAD PHARMA ARIA: Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research